Centre of expertise for research in immuno-oncology and transplantation
Calls for projects

Discover the calls for projects of the DHU Oncogreffe

Ongoing calls for proposal

Call for project conference travel grants

The DHU ONCOGREFFE proposes several funding actions to support research and dissemination of research results. Launched in May 2015, the call for proposal entitled “Conference travel grant” is devoted to promoting the diffusion of research findings in care and research in DHU’s thematic areas : oncology, immunotransplantation and nuclear medicine.
Eligibility criteria:
Applicant : young researcher, physician, engineer, paramedical staff. Applicants must be DHU Oncogreffe member.
The topics of interest of the conference must fit in the thematic areas of the DHU Oncogreffe.
Have an abstract accepted for a presentation (oral or poster) at a national or international conference.
Funding:
The funding amount will be awarded by decision of the scientific committee based on the conference location (up to a maximum grant of € 500 for a local congress, € 800 for a European congress, € 1500 for a congress outside Europe). This amount may cover registration fees, travel and accommodation. It will be paid after the holding of the conference on original receipts. The grant will be confirmed after acceptance of an abstract for oral or poster. Successful applicants will receive the funding from the Nantes University after the meeting on presentation of receipts.
Deadline:
All applications must be submitted at least 6 weeks before the actual conference
DOWNLOAD the application form
Contacts
chrystelle.richard@chu-nantes.fr, philippe.moreau@chu-nantes.fr

2016


Call for projects proposal

Since its creation in 2013, the DHU Oncogreffe is committed to supporting innovative research projects coming from a close cooperation between care and research teams. By stimulating the merger between scientific disciplines, it allows to create collaborations conducive to therapeutic innovation and the emergence of high-value projects in oncology and immunotransplantation The fourth call for research projects was launched on June 9 2016 with a budget of 100 000€. Nine projects were received and submitted for review by the scientific committee of the DHU Oncogreffe, and 5 projects with high potential in oncology, nuclear medicine and transplant immunology were selected for funding :

Call for project conference travel grants

Within the framework of its mission of training and dissemination, the DHU Oncogreffe offers the opportunity to young researchers, doctors and paramedical to present their research results in conferences. This year, six people have been selected to receive travel grants funded by the DHU to attend congress.

Find here the list of awarded projects

2015


Call for projects proposal

The DHU Oncogreffe supports the emergence of innovative projects through specific call for proposals. The third call for research projects was launched on June 18 2015 and closed on September 14. A budget of 100 000€ was devoted to this call to fund innovative projects in the field of clinical and translational research in oncology, immunology and transplantation, and nuclear medicine. 10 projects were received and submitted for review by the scientific committee of the DHU Oncogreffe, and 4 projects with high potential in oncology and transplant immunology were selected for funding :

Call for project conference travel grants

The DHU ONCOGREFFE proposes several funding actions to support research and dissemination of research results. This year, it has funded 5 young researchers and engineers to present their research finding.
Find here the list of awarded projects

2014


DHU ONCOGREFFE launched in July 2014 its new internal call for projects to finance translational and clinical research projects in oncology, immunology and transplantation, and nuclear medicine. The scientific committee has selected 4 collaborative projects out of the 11 dossiers submitted. These translational and clinical research projects were selected for their scientific quality and fall within the DHU’s preferred research themes:

  • Correlation between overexpression of HLA-E / β2 microglobulin by tumor cells and the phenotype of intratumoral lymphocytes according to the MSI status / MSS colorectal cancer.
    Céline Bossard, EA 4273, Biometadys – Partner: Nadine Gervois , Centre for Research in Cancer Nantes-Angers (CRCNA).
  • Breg cells and their role on Treg cells in rodent models of allograft tolerance and in tolerant patients in clinic.
    Sophie Brouard , Lymphocyte regulation in operational tolerance and chronic rejection, U1064- Partner : Elise Chiffoleau, U1064.
  • Return to the immune future : T cells from iPSC.
    Laurent David , Preclinical models Allo & Xenotransplantation: new therapeutic strategies costimulation blockade,  U1064- Partners :  Nathalie Labarrière, Centre for Research in Cancer Nantes-Angers (CRCNA) and iPS platform.
  • Validation de l’apport de l’endomicroscopie et de la vidéocapsule de l’intestin grêle pour le diagnostic précoce de réaction aigüe du greffon contre l’hôte après allogreffe de cellules souches hématopoïétiques.
    Emmanuel Coron, Gastrointestinal clinical department- Partners : Patrice  Chevallier, Thierry Guillaume,  Nicolas Musquer, Clinical Haematology department.

2013


DHU ONCOGREFFE launched its 1st call for research projects in June 2013. The Oncogreffe scientific committee assessed 8 translational and clinical research projects. The interface between the different themes and the innovative nature of the projects were the essential criteria for selection. 4 projects were selected :

  • MicroPET imaging using a murine model of hepatic metastases of colorectal origin. Comparison of bioluminescence, PET-18FDG, PET-68Ga with anti-ACE targeting in one and two stages.
    Fanny Foubert, Eric Frampas, Tamara Matysiak-Budnik, Francoise Kraeber-Bodéré, Yann Touchefeu (Collaboration Digestive oncology/Nuclear medicine/Radiology Departments and Centre for Research in Cancer Nantes-Angers (CRCNA) ).
  • In vitro study of cross-presentation of the CD-Tols used within the context of the European project. The ONE Study and potential regulator in a GVHD model in humanised mice.
    Marie Cristina Cuturi, Bernard Vanhove, Jean Francois Fonteneau, Marc Grégoire, Emilie Varey (Collaboration U1064 and Centre for Research in Cancer Nantes-Angers (CRCNA) ).
  • Clinical and genetic characteristics and innate immunity of melanoma in organ transplant patients.
    Annabelle Brocard and Brigitte Dréno. (Collaboration : Dermato-cancerology and Urology nephrology Departments).
  • Retrospective study based on a large cohort of patients included in the LyMA clinical trial to determine, during diagnosis, the impact of chromosome anomalies, metabolic data (FDG-PET) and clinical-biological data on prediction of the response to treatment and survival in mantle-cell lymphoma (MCL) in young patients. (LyMA-chromo-PET project).
    Steven Le Gouill, Caroline Bodet Millin, Françoise Kraeber Bodéré, Stéphane Minvielle (Collaboration Clinical Haematology/Nuclear Medicine Departements and Mixed Cancer Genomics Unit (UMGC)).

 

Comments are closed.